Today: 18 March 2026
Unilever share price today: ULVR edges higher near 5,070p ahead of Feb 12 results
4 February 2026
1 min read

Unilever share price today: ULVR edges higher near 5,070p ahead of Feb 12 results

London, Feb 4, 2026, 08:32 GMT — Regular session

  • Unilever shares nudged higher in early London action, extending the rally from the previous two sessions.
  • A routine voting-rights filing drew focus away from core issues and onto disclosure details.
  • All eyes are on Thursday’s Bank of England decision and Unilever’s earnings report due next week.

Unilever (ULVR.L) shares edged up 0.4% to 5,066 pence by 0817 GMT, after opening at 5,033 pence and moving between 5,031 and 5,069 earlier this Wednesday. The stock ended Tuesday at 5,045 pence, up 1.1% for the day. Share Prices

The steady climb comes after a steep selloff in AI-exposed UK stocks pushed the FTSE 100 off an intraday record on Tuesday. “Risk appetite just isn’t fully restored,” noted Ipek Ozkardeskaya, senior analyst at Swissquote Bank, pointing to recent swings in commodity-linked shares. Reuters

Sterling assets drew strong buying interest this week, sending London’s blue-chip index to a record high close on Monday. The jump was driven by a rotation into defensive stocks, known for their more stable earnings during shaky growth periods. Ozkardeskaya said the trend “reflected improving global risk sentiment,” even as commodity markets remained volatile. Reuters

Unilever revealed little fresh detail internally. In a regulatory filing Monday, it stated its issued share capital stood at 2,181,005,247 ordinary shares as of Jan. 30. Out of these, 2,180,690,335 shares had voting rights, excluding a small block held inside the group. TradingView

Shareholders rely on these “total voting rights” statements as the basis to figure out if they need to report stakes or changes under UK rules. Typically, they go unnoticed unless they signal a significant capital shift.

Unilever’s next big date is Feb. 12, when it reports Q4 and full-year 2025 results. Five days later, on Feb. 17, the company is lined up to present at the CAGNY consumer conference, providing another critical investor update. Unilever

Investors are looking for a clear signal on whether volume is increasing or if sales continue to rely on price cuts. This is crucial as consumers remain cautious about rising grocery bills while retailers ramp up promotions.

Unilever’s portfolio clearly slots it into the global consumer staples arena, going head-to-head with Nestlé and Procter & Gamble. Investors usually zero in on key indicators: volume shifts, pricing power, and signs that rising costs might be eating into margins again.

That said, the setup carries risks. If Unilever flags weaker margins, increased discounting, or softer demand in crucial markets, the recent rally could quickly reverse—especially if risk appetite takes another hit.

Traders are zeroing in on Thursday’s Bank of England decision, watching closely for shifts in the interest rate outlook. After that, all eyes will shift to Unilever’s earnings report on Feb. 12, which has the potential to alter 2026 forecasts.

Stock Market Today

  • BrightSpring Health Services Posts Strong Q4 Earnings in Senior Care Sector
    March 18, 2026, 9:51 AM EDT. BrightSpring Health Services (NASDAQ:BTSG) delivered a robust Q4 performance with revenues rising 16.3% to $3.55 billion, surpassing analysts' estimates by 5%. The company's earnings beat highlights growing demand in senior health, home health, and hospice care industries, driven by an aging population and chronic disease prevalence. Despite labor shortages and reimbursement challenges, BrightSpring's full-year EBITDA guidance exceeded expectations. The sector saw a 1.1% revenue beat on average, though stocks slipped 7.7% post-earnings. BrightSpring's shares gained 4.9% after results, reflecting investor confidence ahead. Pennant Group (NASDAQ:PNTG) also showed strong growth, up 52.6% year-on-year with $288 million revenue. Ongoing investments in technology and personalized in-home care remain critical for navigating regulatory and workforce pressures in this labor-intensive sector.
GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool
Previous Story

GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool

Lloyds share price jumps toward a fresh high as corporate banking push report lands
Next Story

Lloyds share price jumps toward a fresh high as corporate banking push report lands

Go toTop